Articles: chronic.
-
Slide PresentationPRESENTED ON: Monday, March 24, 2014 at 10:45 AM - 11:45 AMPURPOSE: Recently, the CAT is recommended as a promising tool for assessing the impact of COPD on the indivudual patient. Although it was known that COPD patients have a high frequency of comorbidities, little known about the contribution of these comorbidities to CAT score. We aimed to assess the impact of comorbidities on disease specific health status as assessed by CAT in patients with stable COPD. ⋯ The following authors have nothing to disclose: Sibel Atis Nayci, Eylem Sercan Özgür, Cengiz Özge, Yasin Duman, Ahmet IlvanNo Product/Research Disclosure Information.
-
Tuberculosis Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Pulmonary tuberculosis is an ancient contagious disease which remains a public health issue due to a large reservoir of latent infection (1). ⋯ So, we should always treat tuberculosis as a life-threatening infectious disease which remains a major global health issue, especially due to dormant bacteria.Reference #1: WHO 2010. Global tuberculosis control-surveillance, planning, financing. Geneva, Switzerland: WHO.Reference #2: Allwood BW, Myer L, Bateman ED A Systematic Review of the Association between Pulmonary Tuberculosis and the Development of ChronicAirflow Obstruction in Adults. Respiration. 2013 May 3DISCLOSURE: The following authors have nothing to disclose: Bianca Paraschiv, Claudia Lucia Toma, Stefan Dumitrache-Rujinski, Liliana Grigoriu, Ionela Nicoleta Belaconi, Codin Saon, Miron Alexandru BogdanNo Product/Research Disclosure Information.
-
Lung Cancer IISESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 12:15 PM - 01:15 PMPURPOSE: Biomarkers are of importance for understanding the biology of disease and in diagnosis and treatment planning. MicroRNAs are short non-coding ribonucleotide chains which modify the expression of multiple genes and pathways. MicroRNAs in BAL and bronchial washings may prove useful as prognostic/ predictive and monitoring markers. However, microRNA measurements in these samples have yet to be established. We present data from a pilot study in which microRNAs implicated in lung cancer were measured. ⋯ S. Kaduthanam: Grant monies (from sources other than industry): grant from federal ministry Ruprecht Kuner: Grant monies (from sources other than industry): grant from federal ministry The following authors have nothing to disclose: Amanda Tufman, Fernando Gamarra, Rosi Kiefl, Rudolf Huberresearch on potential biomarkers and pathogenesis of lung diseases.
-
OSA & COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To determine the prevalence of COPD in patients with OSAHS treated in a specific unit of sleep-disordered breathing. ⋯ The following authors have nothing to disclose: Elena Ojeda, Soledad Lopez, Liliana Moran, Paula Rodriguez, Irene Jarana, Pilar DeLucasNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To outline the resource use and costs a U.S. health plan can anticipate during the evaluation and first year of treatment of a CTEPH patient ⋯ Vijay Joish: Employee: employee of bayer sponsor of study Christine Divers: Employee: employee of bayer sponsor of study Chakkarin CBurudpakdee: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Anshul Shah: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Stephen Mathai: Consultant fee, speaker bureau, advisory committee, etc.: consultant to bayer sponsor of studyNo Product/Research Disclosure Information.